The 3rd LNP Characterization and Analytical Development Summit is dedicated to revolutionizing your LNP drug product quality, safety, efficacy and regulatory compliance.
Topics
Biophysical characterization to comprehend LNP in vivo and in vitro behavior
Different characterization techniques for early- stage development to select the most robust methods: fluorescence, chromatography, imaging, and cryo-EM
Potency assays for safety and quality assessments, employing gold standard techniques and validated assays
Complex LNP drug products with targeting moieties and multiple payloads across oligonucleotides, CRISPR-Cas9, RNAs, and beyond
Robustly tested critical quality attributes and release criteria for confidence in pipeline development and regulatory submission
